Financial calendar

February 14, 2024

Year-End Report 2023

March 27, 2024

Annual Report 2023

may 8, 2024

Interim report Q1 2024

May 21, 2024

Annual General Meeting

august 7, 2024

Interim report Q2 2024

november 6, 2024

Interim report Q3 2024

February 12, 2025

Year-End Report 2024


20 MARch 2024

Redeye Theme: Commercialization in Life Science
Presentation by Xspray’s Chief Commercial Officer Edward Jordan who is in charge of the company’s upcoming US-launch.
09.00-12.30 CET
Xspray’s presentation scheduled to start 11.10 CET
Watch live stream at


Previous Events

24 january, 2024

Redeye Fight Cancer – Link to webcast



  • Submit to our press releases and get an email every time we publish a press release or report on our website.
  • When clicked on Send I agree that my personal information will be saved. Read more
  • This field is for validation purposes and should be left unchanged.